Z-0501-2016 Class III Terminated
FDA device recall Z-0501-2016 was initiated by Ameditech Inc on Nov 16, 2015 and is designated Class III. Reason for recall: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the… The recall status is terminated (terminated Nov 9, 2016). Affected quantity: 45,584 kits.
Recall details
- Product Type
- Devices
- Report Date
- Dec 30, 2015
- Initiation Date
- Nov 16, 2015
- Termination Date
- Nov 9, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 45,584 kits
Product description
EDI BZO Uncut Sheet - Cup*, Item No. 160170
Reason for recall
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
Distribution pattern
Nationwide Distribution.
Code information
141260 141294 141909 141925 142074 142243 142428 142614 142712 142911 144555 151925 152003 152223 152498 152723 152897 153311 153559 153818 154184 152103
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0501-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026